Hi Bear, Aren't the patients involved in these trials ones who no longer respond to currently available drugs for prostate cancer? If so, results should be available fairly quickly by virtue of those patients hopefully still being with us. What puzzles me is why the dosing of ZEN3694 alone first? I guess these patients are taken off enzalutamide if it's determined that it no longer has any effect? PVLee